Surprising
Asparagus extract plus chemo boosted survival odds by 55% in a meta-analysis — but the evidence is rated low certainty and comes from just two small studies.
This is an early, intriguing signal that a common vegetable extract might help cancer patients live longer when added to standard chemotherapy, but the low-quality evidence means we can't rely on it until larger, properly controlled trials confirm the finding.
A systematic review of 898 cancer patients found that those who took Chinese asparagus granules alongside chemotherapy were about 1.5 times more likely to survive than those on chemo alone. However, the survival benefit came from only two studies, and the overall evidence was graded as low certainty — meaning the results could easily change with better research.
Where this fits in the evidence
This is among the first studies we've indexed on Chinese Asparagus for Improved Survival — treat it as an early signal until more research accumulates.
The study
- Systematic Review
- n = 898
- 2026-03-12
- Frontiers in nutrition
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.